Publication | Closed Access

ICOS activation in combination with electrochemotherapy generates effective anti-cancer immunological responses in murine models of primary, secondary and metastatic disease

Cancer ImmunosurveillanceIcos ActivationImmunologyTumor ImmunityMurine ModelsMetastatic DiseaseImmune Checkpoint InhibitorImmunomodulationImmunotherapeuticsImmunosuppressionImmunotherapyMedicineRadiation OncologyTumor Microenvironment